Under construction – not a live service
Sign in
Taking people in PolandNo phase

Exercise and nerve stimulation for pain, sleep and fatigue in fibromyalgia

Tests exercise training and nerve stimulation in people with fibromyalgia and fatigue.

Plain-language title generated from the registry record
Registry title: Effect of Physical Exercise and Neuromodulation on Pain, Sleep and Fatigue in Patients With Fibromyalgia

Key facts

Where
Warsaw, PolandSee the site

AI summary: who the study is looking for

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with fibromyalgia who also have chronic tiredness and sleep problems. It tests exercise training and a nerve-stimulation device alongside standard physiotherapy.

Age
20 to 80 years
Sex
Women and men can join.
Disease stage
Confirmed fibromyalgia with chronic fatigue symptoms and sleep disturbances, in a stable health condition.

Main reasons for not taking part

  • Cancer
  • Nerve or brain disorders such as multiple sclerosis, stroke, neuralgia or diabetic polyneuropathy
  • Dementia or cognitive impairment
  • Implanted electronic device such as a pacemaker
  • Cannot communicate well enough in Polish to complete the questionnaires

Read by machine on 12 November 2026.

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 20 and 80 years old?

Source: NCT07242573, who can take part

Where in Poland

  • Rehabilitation Clinic, National Institute of Geriatrics, Rheumatology and Rehabilitation (NIGRiR)Warsaw, PolandContact: Filip Królikowski, MScTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Trial details

Who runs it
National Institute of Geriatrics, Rheumatology and Rehabilitation, Poland
Trial code
NCT07242573
Record updated
24 February 2026
Original description
Fibromyalgia (FMS) is a chronic, multifactorial syndrome characterized by widespread pain, fatigue, and cognitive disturbances. This interventional study evaluates the impact of structured physical training using diagnostic-training devices (Zebris treadmill and Alfa balance platform) and transcutaneous neuromodulation (NESA X-Signal) on pain, sleep quality, and overall health status in patients with fibromyalgia and chronic fatigue symptom.Read full original descriptionShow less

Evaluation of the Effect of Individualized Physical Training and Neuromodulation on Pain, Sleep and Fatigue in Patients With Fibromyalgia: a Randomized Controlled Trial

Fibromyalgia (FMS) is a chronic, multifactorial syndrome characterized by widespread pain, fatigue, and cognitive disturbances. This interventional study evaluates the impact of structured physical training using diagnostic-training devices (Zebris treadmill and Alfa balance platform) and transcutaneous neuromodulation (NESA X-Signal) on pain, sleep quality, and overall health status in patients with fibromyalgia and chronic fatigue symptom.

Participants are allocated into three groups:

1. Physical training + conventional physiotherapy, 2. Transcutaneous neuromodulation + conventional physiotherapy, 3. Control (conventional physiotherapy only). The results will support the development of evidence-based rehabilitation protocols for fibromyalgia patients.

Inclusion: Age between 20 and 80 years; Confirmed diagnosis of fibromyalgia; Presence of chronic fatigue symptoms; Stable health condition; Presence of sleep disturbances; Ability to provide written informed consent and cooperate during the study.

Exclusion: Cancer; Neurological disorders (e.g., neuralgia, multiple sclerosis, diabetic polyneuropathy, stroke); Diagnosed dementia or cognitive impairment; Internal bleeding or acute febrile illness; Infectious skin diseases (e.g., mycosis, purulent dermatitis); Lack of informed consent or cooperation; Refusal to undergo procedures beyond standard NFZ physiotherapy; Implanted electronic devices (e.g., pacemaker); Acute thrombophlebitis; Hysteria or electric phobia; Neurotic addiction to stimulation; Inability to communicate in Polish sufficiently to complete questionnaires or follow instructions.

ClinicalTrials.gov NCT07242573